Aileron Therapeutics’ unraveling has entered its endgame. An early look at phase 1b data persuaded the biotech to call it quits on development of its sole drug candidate—and lay off most of its ...
Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. Now, the biotech has distanced itself from its premerger form by rebranding ...
Lam Aviation advertised substantial performance gains (speed, fuel, climb, useful load) on a test aircraft, initially implying these improvements stemmed from their novel Lam aileron. The Lam aileron ...
Aileron Therapeutics, Inc. (ALRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Shares of Aileron Therapeutics, Inc. (ALRN) have been struggling lately and have lost 21% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...
A new partnership between JobsOhio and Aileron in Tipp City will provide intense training and mentoring to a group of small businesses statewide, J.P. Nauseef, president and CEO of JobsOhio, announced ...
Investigators are attempting to understand the reason behind unresponsive ailerons on De Havilland Canada Dash 8-400 turboprops, an anomaly discovered during a separate probe into an aileron cable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results